Moritz Suppliet : Citation Profile

Are you Moritz Suppliet?

Universiteit van Tilburg (80% share)
Universiteit van Tilburg (20% share)

3

H index

1

i10 index

35

Citations

RESEARCH PRODUCTION:

3

Articles

15

Papers

RESEARCH ACTIVITY:

   9 years (2011 - 2020). See details.
   Cites by year: 3
   Journals where Moritz Suppliet has often published
   Relations with other researchers
   Recent citing documents: 1.    Total self citations: 13 (27.08 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/psu347
   Updated: 2024-11-04    RAS profile: 2020-10-05    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Moritz Suppliet.

Is cited by:

Dubois, Pierre (4)

Sæthre, Morten (4)

Herr, Annika (4)

Bokhari, Farasat (3)

Cavenaile, Laurent (2)

Mendez, Susan (2)

Roldan-Blanco, Pau (2)

Pammolli, Fabio (2)

Unsorg, Maximiliane (2)

Costa, Eduardo (2)

Stuehmeier, Torben (1)

Cites to:

Herr, Annika (13)

Duso, Tomaso (10)

Kaiser, Ulrich (7)

Ganslandt, Mattias (7)

Maskus, Keith (7)

Mendez, Susan (7)

Kyle, Margaret (6)

Klein, Tobias (6)

Lakdawalla, Darius (5)

Ching, Andrew (5)

Ullrich, Hannes (5)

Main data

Where Moritz Suppliet has published?

Journals with more than one article published# docs
Journal of Health Economics2

Working Papers Series with more than one paper published# docs
DICE Discussion Papers / Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE)2

Recent works citing Moritz Suppliet (2024 and 2023)

YearTitle of citing document
2023Pharmaceutical regulation under market integration through parallel trade. (2023). Birg, Laura. In: Canadian Journal of Economics/Revue canadienne d'économique. RePEc:wly:canjec:v:56:y:2023:i:4:p:1322-1346.

Full description at Econpapers || Download paper

Works by Moritz Suppliet:

YearTitleTypeCited
2015Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG In: Perspektiven der Wirtschaftspolitik.
[Full Text][Citation analysis]		article1
2014Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG.(2014) In: DICE Ordnungspolitische Perspektiven.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 1		paper
2014The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-Diabetics In: Discussion Papers of DIW Berlin.
[Full Text][Citation analysis]		paper22
2014The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics.(2014) In: Health, Econometrics and Data Group (HEDG) Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 22		paper
2014The welfare impact of parallel imports: A structural approach applied to the German market for oral anti-diabetics.(2014) In: DICE Discussion Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 22		paper
2014The welfare impact of parallel imports: A structural approach applied to the German market for oral antidiabetics.(2014) In: VfS Annual Conference 2014 (Hamburg): Evidence-based Economic Policy.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 22		paper
2017Tiered co-payments, pricing, and demand in reference price markets for pharmaceuticals In: Journal of Health Economics.
[Full Text][Citation analysis]		article3
2020Umbrella branding in pharmaceutical markets In: Journal of Health Economics.
[Full Text][Citation analysis]		article3
2017Umbrella Branding in Pharmaceutical Markets.(2017) In: Discussion Paper.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 3		paper
2017Umbrella Branding in Pharmaceutical Markets.(2017) In: Discussion Paper.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 3		paper
2017Umbrella Branding in Pharmaceutical Markets.(2017) In: Other publications TiSEM.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 3		paper
2017Umbrella Branding in Pharmaceutical Markets.(2017) In: Other publications TiSEM.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 3		paper
2016Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets In: Discussion Paper.
[Full Text][Citation analysis]		paper6
2016Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets.(2016) In: Discussion Paper.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 6		paper
2016Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets.(2016) In: Other publications TiSEM.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 6		paper
2016Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets.(2016) In: Other publications TiSEM.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 6		paper
2011Co-Payment Exemptions and Reference Prices: an Empirical Study of Pharmaceutical Prices in Germany.(2011) In: Health, Econometrics and Data Group (HEDG) Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 6		paper
2012Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany.(2012) In: DICE Discussion Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 6		paper

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team